Cardiac Sympathetic Nerve Function in Patients with Severe Aortic Stenosis Prior and After Transcatheter Aortic Valve Implantation: Evaluation by 5-Year Risk Model

Overview

Journal Ann Nucl Cardiol

Date 2024 Dec 5

PMID 39635331

Authors

Ryuta Egi

Kenji Fukushima

Yohji Matsusaka

Tomohiko Yamane

Akira Seto

Ichiro Matsunari

Yoshie Nakajima

Shintaro Nakano

Ichiei Kuji

Affiliations

Soon will be listed here.

Abstract

: While the non-invasive assessment of cardiac sympathetic nerve dysfunction is readily accessible, its applicability in invasive intervention for structural heart disease has received limited investigation. Our study aimed to clarify the cardiac sympathetic nerve function in patients with severe Aortic stenosis (AS) and its postoperative changes after transcatheter aortic valve implantation (TAVI) using I-metaiodobenzylguanidine scintigraphy (MIBG) in combination with 5-year mortality prediction model. : Consecutive 26 patients (83±5ys, male 4) with severe AS who underwent MIBG prior TAVI procedures were retrospectively enrolled. Of those, 15 patients underwent postoperative-follow up MIBG. The early and delayed heart-to-mediastinum ratio (e- and d-H/M), and washout rate (WR) were obtained from MIBG planner imaging. The MIBG 5-year mortality prediction model was employed to compare pre and after TAVI. Cardiac function and wall thickness were evaluated with transthoracic echocardiography. : Preoperative e-H/M, d-H/M, and WR were 2.4±0.5, 2.3±0.4, and 29±14% respectively, and WR showed significant correlation to left ventricular ejection fraction (LVEF) and brain natriuretic peptide (BNP) (r=-0.4 and 0.6; p=0.03, and 0.001 for LVEF and BNP, respectively). 102±28 days after TAVI, either H/M or WR did not show significant improvement among enrolled patients (2.5±0.3, 2.3±0.4, and 30±11% for e-, d-H/M, and WR for after TAVI), while the BNP level was significantly reduced (128±691 and 94±194 pg/dl, for pre vs. after, p=0.008). Five patients showed a significant recovery in WR (37.0±13.8 and 28.8±8.5% for pre and post, p=0.04), and left ventricular wall thickness was significantly thinner compared to those who did not recover (15.2±3.2 vs 11.2±2.4, p=0.02; 14.2±2.9 vs 10.8±1.8, p=0.02 for intraventricular septum and posterior wall, respectively). In 5-year prediction risk model, 7 patients showed a significant reduction in mortality risk, and the patients who did not show risk reduction had significantly reduced renal function (eGFR 57.5±18.8 vs. 38.2±11.3 ml/min/1.73m, p=0.03 for recovered vs. not recovered). : After a 3-month follow-up after TAVI, diverse response in cardiac MIBG parameters were observed among patients with severe AS, despite successful valve replacement. Cardiac MIBG serves as a non-invasive tool that can comprehensively evaluate and surrogate the severity of heart failure resulting from a multi-factorial condition.

References

Devereux R . Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension. 1987; 9(2 Pt 2):II19-26. DOI: 10.1161/01.hyp.9.2_pt_2.ii19. View

Nakajima K, Nakata T . Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan. J Nucl Med. 2015; 56 Suppl 4:11S-19S. DOI: 10.2967/jnumed.114.142794. View

Yokoyama H, Shishido K, Mizuno S, Yamanaka F, Saito S . Early Effect of Transcatheter Mitral Valve Repair on Cardiac Sympathetic Nerve Activity. Struct Heart. 2023; 7(3):100153. PMC: 10236802. DOI: 10.1016/j.shj.2022.100153. View

Kurata C, Wakabayashi Y, Shouda S, Okayama K, Yamamoto T, Ishikawa A . Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med. 1995; 36(11):2037-43. View

Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T . Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2005; 45(5):661-7. DOI: 10.1016/j.jacc.2004.11.038. View

Kadoya Y, Zen K, Tamaki N, Ito N, Kuwabara K, Yamano M . Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by I-metaiodobenzylguanidine scintigraphy in patients with severe aortic valve stenosis. Eur J Nucl Med Mol Imaging. 2019; 47(7):1657-1667. DOI: 10.1007/s00259-019-04523-0. View

Gargiulo P, Acampa W, Asile G, Abbate V, Nardi E, Marzano F . I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation. Eur J Nucl Med Mol Imaging. 2022; 50(3):813-824. PMC: 9852124. DOI: 10.1007/s00259-022-05941-3. View

Liga R, Gimelli A, De Carlo M, Marzullo P, Pedrinelli R, Petronio A . Cardiac sympathetic dysfunction in left ventricular hypertrophy caused by arterial hypertension and degenerative aortic stenosis. J Nucl Cardiol. 2020; 29(1):337-347. DOI: 10.1007/s12350-020-02250-w. View

Travin M, Matsunari I, Thomas G, Nakajima K, Yoshinaga K . How do we establish cardiac sympathetic nervous system imaging with I-mIBG in clinical practice? Perspectives and lessons from Japan and the US. J Nucl Cardiol. 2018; 26(4):1434-1451. DOI: 10.1007/s12350-018-1394-5. View

10.

Pibarot P, Lancellotti P, Narula J . Concomitant Cardiac Amyloidosis in Severe Aortic Stenosis: The Trojan Horse?. J Am Coll Cardiol. 2020; 77(2):140-143. DOI: 10.1016/j.jacc.2020.11.007. View

11.

Zile M, Gaasch W . Heart failure in aortic stenosis - improving diagnosis and treatment. N Engl J Med. 2003; 348(18):1735-6. DOI: 10.1056/NEJMp030035. View

12.

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

13.

Momose M, Kobayashi H, Ikegami H, Nagamatsu H, Sakomura Y, Aomi S . Total and partial cardiac sympathetic denervation after surgical repair of ascending aortic aneurysm. J Nucl Med. 2001; 42(9):1346-50. View

14.

Hillege H, Nitsch D, Pfeffer M, Swedberg K, McMurray J, Yusuf S . Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5):671-8. DOI: 10.1161/CIRCULATIONAHA.105.580506. View

15.

Kasama S, Toyama T, Kaneko Y, Iwasaki T, Sumino H, Kumakura H . Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events. Eur J Nucl Med Mol Imaging. 2012; 39(6):1056-64. DOI: 10.1007/s00259-012-2092-1. View

16.

Nakajima K, Matsumoto N, Kasai T, Matsuo S, Kiso K, Okuda K . Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database. Ann Nucl Med. 2016; 30(3):188-99. PMC: 4819542. DOI: 10.1007/s12149-016-1065-z. View

17.

Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T . Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med. 2002; 43(10):1279-85. View

18.

Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K . Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol. 2010; 18(1):82-9. DOI: 10.1007/s12350-010-9313-4. View

19.

Sharabiani M, Fiorentino F, Angelini G, Patel N . Long-term survival after surgical aortic valve replacement among patients over 65 years of age. Open Heart. 2016; 3(1):e000338. PMC: 4809186. DOI: 10.1136/openhrt-2015-000338. View

20.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022; 79(17):e263-e421. DOI: 10.1016/j.jacc.2021.12.012. View